$FBYD
Falcon's Beyond Global, Inc. Stock $fbyd

$fbyd Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024044383 Filed on May 16, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$1.516M	$2.147M	$0.00
YoY Change
Cost Of Revenue	$0.00	$0.00
YoY Change
Gross Profit	$1.516M	$2.147M
YoY Change
Gross Profit Margin	100.0%	100.0%
Selling, General & Admin	$6.793M	$5.315M	$1.220M
YoY Change	456.8%	1030.85%	269.7%
% of Gross Profit	448.09%	247.55%
Research & Development	$16.00K	-$3.000K	$463.0K
YoY Change	-96.54%
% of Gross Profit	1.06%	-0.14%
Depreciation & Amortization	$1.000K	$1.000K	$1.342M
YoY Change	-99.93%
% of Gross Profit	0.07%	0.05%
Operating Expenses	$6.829M	$5.313M	$1.220M
YoY Change	459.75%	1030.43%	269.7%
Operating Profit	-$5.313M	-$3.166M	-$8.902M
YoY Change	-40.32%
Interest Expense	-$12.00K	-$48.23M	$4.090M
YoY Change	-100.29%	-7879.52%	-23.55%
% of Operating Profit
Other Income/Expense, Net	$118.8M	-$348.4M	$250.0K
YoY Change	47429.2%	-183460.53%
Pretax Income	$114.0M	-$416.9M	$3.120M
YoY Change	3554.58%	-119210.57%	-37.85%
Income Tax	-$1.000K	-$299.0K	$410.0K
% Of Pretax Income	0.0%		13.14%
Net Earnings	$114.0M	-$33.26M	$2.710M
YoY Change	4107.53%	110773.33%	-46.02%
Net Earnings / Revenue	7521.37%	-1549.23%
Basic Earnings Per Share	$1.90	-$6.71
Diluted Earnings Per Share	$1.53	-$4.69	$0.11
COMMON SHARES
Basic Shares Outstanding	9.022M shares	7.095M shares
Diluted Shares Outstanding	9.209M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.050M	$672.0K	$700.0K
YoY Change	50.0%	12.0%	250.0%
Cash & Equivalents	$1.050M	$672.0K	$1.551M
Short-Term Investments
Other Short-Term Assets	$3.303M	$1.061M	$100.0K
YoY Change	3203.0%	961.0%	-66.67%
Inventory
Prepaid Expenses
Receivables	$1.794M	$696.0K
Other Receivables	$0.00	$393.0K
Total Short-Term Assets	$6.147M	$2.429M	$800.0K
YoY Change	668.38%	304.83%	60.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.00K	$23.00K
YoY Change		-97.13%
Goodwill
YoY Change
Intangibles		$0.00
YoY Change		-100.0%
Long-Term Investments	$1.50	$6.80	$73.60M
YoY Change	-100.0%	-100.0%	-66.89%
Other Assets	$322.0K	$264.0K
YoY Change		-60.66%
Total Long-Term Assets	$61.64M	$60.93M	$73.60M
YoY Change	-16.26%	-10255.0%	-66.89%
TOTAL ASSETS
Total Short-Term Assets	$6.147M	$2.429M	$800.0K
Total Long-Term Assets	$61.64M	$60.93M	$73.60M
Total Assets	$67.78M	$63.36M	$74.40M
YoY Change	-8.89%		-66.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.524M	$3.852M	$3.300M
YoY Change	97.7%	48.15%	1000.0%
Accrued Expenses	$20.74M	$20.84M	$1.700M
YoY Change	1120.06%	10320.0%	1600.0%
Deferred Revenue
YoY Change
Short-Term Debt	$8.471M		$2.100M
YoY Change	303.38%
Long-Term Debt Due	$6.660M	$6.651M
YoY Change		-10.22%
Total Short-Term Liabilities	$197.7M	$214.4M	$7.200M
YoY Change	2646.21%	5397.38%	2300.0%
LONG-TERM LIABILITIES
Long-Term Debt	$20.48M	$22.97M	$0.00
YoY Change
Other Long-Term Liabilities	$5.500M	$5.500M	$12.30M
YoY Change	-55.28%	-61.81%	11.82%
Total Long-Term Liabilities	$25.98M	$28.47M	$12.30M
YoY Change	111.19%	97.67%	11.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$197.7M	$214.4M	$7.200M
Total Long-Term Liabilities	$25.98M	$28.47M	$12.30M
Total Liabilities	$442.1M	$552.4M	$19.50M
YoY Change	2167.12%		71.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.40M	-$68.59M
YoY Change		184.07%
Common Stock		$11.70M
YoY Change		11698999900.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$61.72M	-$57.11M	$54.90M
YoY Change
Total Liabilities & Shareholders Equity	$67.78M	$63.36M	$74.40M
YoY Change	-8.89%		-66.61%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	$114.0M	-$33.26M	$2.710M
YoY Change	4107.53%	110773.33%	-46.02%
Depreciation, Depletion And Amortization	$1.000K	$1.000K	$1.342M
YoY Change	-99.93%
Cash From Operating Activities	-$3.768M	-$7.001M	-$940.0K
YoY Change	300.85%	872.36%	118.6%
INVESTING ACTIVITIES
Capital Expenditures	$4.000K	$1.000K	$133.0K
YoY Change	-96.99%
Acquisitions
YoY Change
Other Investing Activities	-$2.092M	-$478.0K	$153.1M
YoY Change	-101.37%	-166.39%
Cash From Investing Activities	-$2.096M	-$479.0K	$153.1M
YoY Change	-101.37%	-166.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$153.2M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.231M	7.446M	-152.0M
YoY Change	-104.1%
NET CHANGE
Cash From Operating Activities	-$3.768M	-7.001M	-940.0K
Cash From Investing Activities	-$2.096M	-479.0K	153.1M
Cash From Financing Activities	$6.231M	7.446M	-152.0M
Net Change In Cash	$367.0K	-34.00K	130.0K
YoY Change	182.31%	-14602888806400500.0%	-130.23%
FREE CASH FLOW
Cash From Operating Activities	-$3.768M	-$7.001M	-$940.0K
Capital Expenditures	$4.000K	$1.000K	$133.0K
Free Cash Flow	-$3.772M	-$7.002M	-$1.073M
YoY Change	251.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41833
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Falcon’s Beyond Global, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	92-0261853
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1768 Park Center Drive
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32835
CY2024Q1	dei	City Area Code CityAreaCode	(407)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	909-9350
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1050000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	672000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1794000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	696000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3303000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1061000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6147000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2429000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	61292000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	60643000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	322000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	264000	usd
CY2024Q1	us-gaap	Assets Assets	67783000	usd
CY2023Q4	us-gaap	Assets Assets	63359000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6524000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3852000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	20741000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	20741000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	20840000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	8471000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6660000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6651000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6651000	usd
CY2024Q1	fbyd	Earnout Liabilities Current EarnoutLiabilitiesCurrent	155331000	usd
CY2023Q4	fbyd	Earnout Liabilities Current EarnoutLiabilitiesCurrent	183055000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	197727000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	214398000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5500000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5500000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20476000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22965000	usd
CY2024Q1	fbyd	Earnout Liabilities Non Current EarnoutLiabilitiesNonCurrent	214695000	usd
CY2023Q4	fbyd	Earnout Liabilities Non Current EarnoutLiabilitiesNonCurrent	305586000	usd
CY2024Q1	fbyd	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	3691000	usd
CY2023Q4	fbyd	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	3904000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	442089000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	552353000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-10086000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11699000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51425000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68594000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-215000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-216000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-61720000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-57105000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-312586000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-431889000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-374306000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-488994000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67783000	usd
CY2024Q1	us-gaap	Revenues Revenues	1516000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	6288000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6793000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9749000	usd
CY2024Q1	fbyd	Transaction Expenses TransactionExpenses	7000	usd
CY2024Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	12000	usd
CY2023Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	254000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-12000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	463000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1342000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	6829000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	18096000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5313000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8902000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1154000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1279000	usd
CY2024Q1	fbyd	Interest Income Operating Expenses InterestIncomeOperatingExpenses	-269000	usd
CY2023Q1	fbyd	Interest Income Operating Expenses InterestIncomeOperatingExpenses	-271000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	3000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-208000	usd
CY2024Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability	-118615000	usd
CY2024Q1	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	-375000	usd
CY2023Q1	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	599000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	114023000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9853000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000	usd
CY2024Q1	fbyd	Earnout Liabilities Current EarnoutLiabilitiesCurrent	155331000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	214398000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5500000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5500000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20476000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22965000	usd
CY2024Q1	fbyd	Earnout Liabilities Non Current EarnoutLiabilitiesNonCurrent	214695000	usd
CY2023Q4	fbyd	Earnout Liabilities Non Current EarnoutLiabilitiesNonCurrent	305586000	usd
CY2024Q1	fbyd	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	3691000	usd
CY2023Q4	fbyd	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	3904000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	442089000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	552353000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-10086000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51425000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68594000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-215000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-216000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-57105000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-431889000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67783000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63359000	usd
CY2024Q1	us-gaap	Revenues Revenues	1516000	usd
CY2023Q1	us-gaap	Revenues Revenues	9194000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	6288000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6793000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9749000	usd
CY2024Q1	fbyd	Transaction Expenses TransactionExpenses	7000	usd
CY2024Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	12000	usd
CY2023Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	254000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-12000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-254000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	463000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1342000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	6829000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5313000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8902000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1154000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	3000	usd
CY2024Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability	-118615000	usd
CY2024Q1	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	-375000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	114023000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9853000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9850000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	96855000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17169000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.9
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.53
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9021520	shares
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9850000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	96855000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17169000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.9
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.53
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9021520	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9209020	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9850000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	114028000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9567000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	96858000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17170000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1342000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-185000	usd
CY2024Q1	fbyd	Foreign Exchange Transaction Lossgain ForeignExchangeTransactionLossgain	-375000	usd
CY2023Q1	fbyd	Foreign Exchange Transaction Lossgain ForeignExchangeTransactionLossgain	607000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1154000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1279000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	usd
CY2024Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	12000	usd
CY2023Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	254000	usd
CY2024Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	12000	usd
CY2023Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	254000	usd
CY2024Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability	-118615000	usd
CY2024Q1	fbyd	Fair Value Adjustment Of Of Earnouts FairValueAdjustmentOfOfEarnouts	-208000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	346000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1174000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1428000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	1133000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	845000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-73000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	89000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	107000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-334000	usd
CY2023Q1	fbyd	Increase Decrease In Other Current Assets Relatedparty IncreaseDecreaseInOtherCurrentAssetsRelatedparty	2215000	usd
CY2023Q1	fbyd	Increase Decrease In Capitalization Of Ride Media Content IncreaseDecreaseInCapitalizationOfRideMediaContent	60000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	465000	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	1227000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-26000	usd
CY2024Q1	fbyd	Increase Decrease In Accounts Payables IncreaseDecreaseInAccountsPayables	241000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2669000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1794000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	33000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	448000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-102000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3791000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9209020	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9850000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	283000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	114028000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	96858000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17170000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9850000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1342000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-185000	usd
CY2024Q1	fbyd	Foreign Exchange Transaction Lossgain ForeignExchangeTransactionLossgain	-375000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1279000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	usd
CY2024Q1	fbyd	Credit Loss Expense From Related Party CreditLossExpenseFromRelatedParty	12000	usd
CY2024Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability	-118615000	usd
CY2024Q1	fbyd	Fair Value Adjustment Of Of Earnouts FairValueAdjustmentOfOfEarnouts	-208000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	346000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1174000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1428000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	1133000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-73000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	89000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	107000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-334000	usd
CY2023Q1	fbyd	Increase Decrease In Other Current Assets Relatedparty IncreaseDecreaseInOtherCurrentAssetsRelatedparty	2215000	usd
CY2023Q1	fbyd	Increase Decrease In Capitalization Of Ride Media Content IncreaseDecreaseInCapitalizationOfRideMediaContent	60000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	465000	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent	1227000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-26000	usd
CY2024Q1	fbyd	Increase Decrease In Accounts Payables IncreaseDecreaseInAccountsPayables	241000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2669000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1794000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	33000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	448000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-102000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3791000	usd
CY2024Q1	fbyd	Increase Decrease In Commodity Contract Assets And Liabilities Related Party IncreaseDecreaseInCommodityContractAssetsAndLiabilitiesRelatedParty	0	usd
CY2023Q1	fbyd	Increase Decrease In Commodity Contract Assets And Liabilities Related Party IncreaseDecreaseInCommodityContractAssetsAndLiabilitiesRelatedParty	-123000	usd
CY2023Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-299000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3768000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6498000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133000	usd
CY2024Q1	fbyd	Shortterm Advances To Affiliates ShorttermAdvancesToAffiliates	2094000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2096000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	40000	usd
CY2024Q1	fbyd	Increase Decrease In Commodity Contract Assets And Liabilities Related Party IncreaseDecreaseInCommodityContractAssetsAndLiabilitiesRelatedParty	0	usd
CY2023Q1	fbyd	Increase Decrease In Commodity Contract Assets And Liabilities Related Party IncreaseDecreaseInCommodityContractAssetsAndLiabilitiesRelatedParty	-123000	usd
CY2023Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-299000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3768000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6498000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133000	usd
CY2024Q1	fbyd	Shortterm Advances To Affiliates ShorttermAdvancesToAffiliates	2094000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2096000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	40000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7221000	usd
CY2024Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1250000	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1182000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	222000	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	427000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	416000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4650000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3000000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-5392000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-2500000	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	111000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6231000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-178000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	367000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	672000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8366000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1050000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	207000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	456000	usd
CY2023Q1	fbyd	Operating Lease Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities OperatingLeaseRightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	514000	usd
CY2024Q1	fbyd	Conversion Of Warrants To Common Shares Class A ConversionOfWarrantsToCommonSharesClassA	7137000	usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	14733000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-488994000	usd
CY2024Q1	fbyd	Stock Issued During Period Value Conversion Of Common Shares StockIssuedDuringPeriodValueConversionOfCommonShares	93000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	567000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-374306000	usd
CY2024Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	6400000	usd
CY2024Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	15700000	usd
CY2024Q1	us-gaap	Investment Company Contributed Capital To Committed Capital Ratio InvestmentCompanyContributedCapitalToCommittedCapitalRatio	1	pure
CY2023Q1	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	300000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51400000	usd
CY2023Q3	us-gaap	Assets Of Wholly Owned Real Estate Investment Subsidiaries AssetsOfWhollyOwnedRealEstateInvestmentSubsidiaries	18000000	usd
CY2023Q3	us-gaap	Investment Company Expense After Reduction Of Fee Waiver And Reimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement	500000	usd
CY2024Q1	fbyd	Capital Deficiency CapitalDeficiency	-191600000	usd
CY2024Q1	fbyd	Earn Out Liability EarnOutLiability	155300000	usd
CY2024Q1	fbyd	Additional Debt Borrowed AdditionalDebtBorrowed	15100000	usd
CY2023Q3	us-gaap	Investments Investments	30000000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7221000	usd
CY2024Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1250000	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1182000	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	427000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4650000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3000000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-5392000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-2500000	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	111000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6231000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-178000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	367000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6809000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	672000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8366000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1050000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1551000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	207000	usd
CY2023Q1	fbyd	Operating Lease Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities OperatingLeaseRightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	514000	usd
CY2024Q1	fbyd	Conversion Of Warrants To Common Shares Class A ConversionOfWarrantsToCommonSharesClassA	7137000	usd
CY2024Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	14733000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-488994000	usd
CY2024Q1	fbyd	Stock Issued During Period Value Conversion Of Common Shares StockIssuedDuringPeriodValueConversionOfCommonShares	93000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	567000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	114024000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-374306000	usd
CY2024Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	6400000	usd
CY2024Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	15700000	usd
CY2024Q1	us-gaap	Investment Company Contributed Capital To Committed Capital Ratio InvestmentCompanyContributedCapitalToCommittedCapitalRatio	1	pure
CY2023Q1	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	300000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51400000	usd
CY2023Q3	us-gaap	Assets Of Wholly Owned Real Estate Investment Subsidiaries AssetsOfWhollyOwnedRealEstateInvestmentSubsidiaries	18000000	usd
CY2023Q3	us-gaap	Investment Company Expense After Reduction Of Fee Waiver And Reimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement	500000	usd
CY2024Q1	fbyd	Capital Deficiency CapitalDeficiency	-191600000	usd
CY2024Q1	fbyd	Earn Out Liability EarnOutLiability	155300000	usd
CY2024Q1	fbyd	Additional Debt Borrowed AdditionalDebtBorrowed	15100000	usd
CY2023Q3	us-gaap	Investments Investments	30000000	usd
CY2024Q1	fbyd	Fcg Received A Closing Payment FCGReceivedAClosingPayment	17500000	usd
CY2024Q1	us-gaap	Investment Company Expense After Reduction Of Fee Waiver And Reimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement	500000	usd
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	30000000	usd
CY2024Q1	fbyd	Annual Compounding Preferred Return Percentage AnnualCompoundingPreferredReturnPercentage	0.09	pure
CY2024Q1	fbyd	Prorata Prorata	0.25	pure
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1100000	usd
CY2024Q1	us-gaap	Revenues Revenues	1516000	usd
CY2024Q1	fbyd	Fcg Received A Closing Payment FCGReceivedAClosingPayment	17500000	usd
CY2024Q1	us-gaap	Investment Company Expense After Reduction Of Fee Waiver And Reimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement	500000	usd
CY2024Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	30000000	usd
CY2024Q1	fbyd	Annual Compounding Preferred Return Percentage AnnualCompoundingPreferredReturnPercentage	0.09	pure
CY2024Q1	fbyd	Prorata Prorata	0.25	pure
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify"><b><i>Concentration of credit risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of Cash and cash equivalents and Accounts receivable. The Company places its Cash and cash equivalents with financial institutions of high credit quality. At times, such amounts exceed federally insured limits. Management believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the respective financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">The Company provides credit to its customers located both inside and outside the United States in its normal course of business. Receivables are presented net of an allowance for credit losses based on the Company’s assessment of the collectability of customer accounts. The Company maintains an allowance that provides for an adequate reserve to cover estimated losses on receivables as well as contract assets. The Company determines the adequacy of the allowance by estimating the probability of loss based on the Company’s historical credit loss experience and taking into consideration current market conditions and supportable forecasts that affect the collectability of the reported amount. The Company regularly evaluates receivable and contract asset balances considering factors such as the customer’s creditworthiness, historical payment experience and the age of the outstanding balance. Changes to expected credit losses during the period are included in Credit loss expense in the Company’s unaudited condensed consolidated statements of operations and comprehensive income (loss). After concluding that a reserved accounts receivable is no longer collectible, the Company reduces both the gross receivable and the allowance for credit losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">The Falcon’s Creative Group segment has significant revenue concentration associated with a few customers. As of July 27, 2023 FCG was deconsolidated and accounted for as an equity method investment in the Company’s unaudited condensed consolidated financial statements. The Falcon’s Creative Group segment is now comprised of the Company’s retained equity method investment in FCG. See Deconsolidation of Falcon’s Creative Group, LLC under Note 1 – Description of business and basis of presentation and Note 4– Investments and advances to equity method investments. FCG revenue continues to depend on one customer, QIC. FCG had one customer with revenues greater than 10% of total revenue, approximately $14.7 million for the three months ended March 31, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">The Company had one customer with revenues greater than 10% of total revenue, approximately $1.5 million for the three months ended March 31, 2024. Accounts receivable, net balances with this one customer totaled $1.8 million (100% of total Accounts receivable, net) as of March 31, 2024. The Company had two customers with revenue greater than 10% of total revenue, approximately $5.4 million for one customer and $3.2 million for the second customer, for the three months ended March 31, 2023.</p>
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	5916000	usd
CY2023Q1	us-gaap	Production Tax Expense ProductionTaxExpense	75000	usd
CY2023Q1	fbyd	Attraction Hardware And Turnkey Sales AttractionHardwareAndTurnkeySales	1874000	usd
CY2024Q1	fbyd	Disaggregated Componentsof Other Revenue DisaggregatedComponentsofOtherRevenue	1516000	usd
CY2024Q1	fbyd	Total Revenue From Services Transferred Over Time TotalRevenueFromServicesTransferredOverTime	1516000	usd
CY2023Q1	fbyd	Total Revenue From Services Transferred Over Time TotalRevenueFromServicesTransferredOverTime	7865000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1329000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1329000	usd
CY2024Q1	us-gaap	Revenues Revenues	1516000	usd
CY2023Q1	us-gaap	Revenues Revenues	9194000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1.5	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3.5	usd
CY2024Q1	fbyd	Related Party Transaction Other Revenues From Transaction With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionWithRelatedParty	1.5	usd
CY2023	us-gaap	Revenues Revenues	9194000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify"><b><i>Concentration of credit risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of Cash and cash equivalents and Accounts receivable. The Company places its Cash and cash equivalents with financial institutions of high credit quality. At times, such amounts exceed federally insured limits. Management believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the respective financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">The Company provides credit to its customers located both inside and outside the United States in its normal course of business. Receivables are presented net of an allowance for credit losses based on the Company’s assessment of the collectability of customer accounts. The Company maintains an allowance that provides for an adequate reserve to cover estimated losses on receivables as well as contract assets. The Company determines the adequacy of the allowance by estimating the probability of loss based on the Company’s historical credit loss experience and taking into consideration current market conditions and supportable forecasts that affect the collectability of the reported amount. The Company regularly evaluates receivable and contract asset balances considering factors such as the customer’s creditworthiness, historical payment experience and the age of the outstanding balance. Changes to expected credit losses during the period are included in Credit loss expense in the Company’s unaudited condensed consolidated statements of operations and comprehensive income (loss). After concluding that a reserved accounts receivable is no longer collectible, the Company reduces both the gross receivable and the allowance for credit losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">The Falcon’s Creative Group segment has significant revenue concentration associated with a few customers. As of July 27, 2023 FCG was deconsolidated and accounted for as an equity method investment in the Company’s unaudited condensed consolidated financial statements. The Falcon’s Creative Group segment is now comprised of the Company’s retained equity method investment in FCG. See Deconsolidation of Falcon’s Creative Group, LLC under Note 1 – Description of business and basis of presentation and Note 4– Investments and advances to equity method investments. FCG revenue continues to depend on one customer, QIC. FCG had one customer with revenues greater than 10% of total revenue, approximately $14.7 million for the three months ended March 31, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.5pt; text-align: justify">The Company had one customer with revenues greater than 10% of total revenue, approximately $1.5 million for the three months ended March 31, 2024. Accounts receivable, net balances with this one customer totaled $1.8 million (100% of total Accounts receivable, net) as of March 31, 2024. The Company had two customers with revenue greater than 10% of total revenue, approximately $5.4 million for one customer and $3.2 million for the second customer, for the three months ended March 31, 2023.</p>
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	5916000	usd
CY2023Q1	us-gaap	Production Tax Expense ProductionTaxExpense	75000	usd
CY2023Q1	fbyd	Attraction Hardware And Turnkey Sales AttractionHardwareAndTurnkeySales	1874000	usd
CY2024Q1	fbyd	Disaggregated Componentsof Other Revenue DisaggregatedComponentsofOtherRevenue	1516000	usd
CY2024Q1	fbyd	Total Revenue From Services Transferred Over Time TotalRevenueFromServicesTransferredOverTime	1516000	usd
CY2023Q1	fbyd	Total Revenue From Services Transferred Over Time TotalRevenueFromServicesTransferredOverTime	7865000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1329000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1329000	usd
CY2024Q1	us-gaap	Revenues Revenues	1516000	usd
CY2023Q1	us-gaap	Revenues Revenues	9194000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1.5	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3.5	usd
CY2024Q1	fbyd	Related Party Transaction Other Revenues From Transaction With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionWithRelatedParty	1.5	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1100000	usd
CY2024Q1	us-gaap	Revenues Revenues	1516000	usd
CY2023	us-gaap	Revenues Revenues	9194000	usd
CY2024Q1	fbyd	Equity Method Investment Ratio EquityMethodInvestmentRatio	1	pure
CY2024Q1	fbyd	Equity Method Investment Recognized Of Gains Orloss EquityMethodInvestmentRecognizedOfGainsOrloss	1	pure
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	61292000	usd
CY2024Q1	fbyd	Equity Method Investment Ratio EquityMethodInvestmentRatio	1	pure
CY2024Q1	fbyd	Equity Method Investment Recognized Of Gains Orloss EquityMethodInvestmentRecognizedOfGainsOrloss	1	pure
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	61292000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	60643000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1154000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1279000	usd
CY2023Q3	us-gaap	Investment Company Total Return Gain Loss On Investment Not Meeting Investment Requirement InvestmentCompanyTotalReturnGainLossOnInvestmentNotMeetingInvestmentRequirement	1	pure
CY2024Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.09	pure
CY2024Q1	us-gaap	Other Investments OtherInvestments	1300000	usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	500000	usd
CY2024Q1	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	800000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	60643000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1279000	usd
CY2023Q3	us-gaap	Investment Company Total Return Gain Loss On Investment Not Meeting Investment Requirement InvestmentCompanyTotalReturnGainLossOnInvestmentNotMeetingInvestmentRequirement	1	pure
CY2024Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.09	pure
CY2024Q1	us-gaap	Other Investments OtherInvestments	1300000	usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	500000	usd
CY2024Q1	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	800000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17294000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17605000	usd
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2211000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2211000	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	654000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	592000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	63000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	9000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	50000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	469000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	423000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20741000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20840000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	400000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	500000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	35607000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29616000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	15131000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	6651000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17294000	usd
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2211000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2211000	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	654000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	592000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	63000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	50000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	469000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	423000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20741000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20840000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	400000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	500000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	35607000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29616000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	15131000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	6651000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20476000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22965000	usd
CY2024Q1	fbyd	Services Fees And Expenses ServicesFeesAndExpenses	11100000	usd
CY2024Q1	us-gaap	Development Costs DevelopmentCosts	300000	usd
CY2024Q1	us-gaap	Life Premiums As Percentage Of Gross Premiums LifePremiumsAsPercentageOfGrossPremiums	0.06	pure
CY2024Q1	fbyd	Agreement Amount AgreementAmount	300000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.85	pure
CY2024Q1	fbyd	Services Fees And Expenses ServicesFeesAndExpenses	11100000	usd
CY2024Q1	us-gaap	Development Costs DevelopmentCosts	300000	usd
CY2024Q1	us-gaap	Life Premiums As Percentage Of Gross Premiums LifePremiumsAsPercentageOfGrossPremiums	0.06	pure
CY2024Q1	fbyd	Agreement Amount AgreementAmount	300000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.85	pure
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	pure
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22965000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Capacity Available For Trade Purchases LineOfCreditFacilityCapacityAvailableForTradePurchases	3914000	usd
CY2021Q4	us-gaap	Investment Owned Foreign Currency Contract Reporting Currency Amount Current Value InvestmentOwnedForeignCurrencyContractReportingCurrencyAmountCurrentValue	10000000	usd
CY2020Q2	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	1500000	eur
CY2021Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	12785000	usd
CY2021Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.0275	pure
CY2019Q1	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	7000000	eur
CY2021Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.02	pure
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2100000	usd
CY2023Q1	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	100000	usd
CY2024Q1	fbyd	Outstanding Balance Conversion Of Debt OutstandingBalanceConversionOfDebt	1800000	usd
CY2023Q4	srt	Bank Loans BankLoans	600000	usd
CY2024Q1	fbyd	Revolving Credit Arrangement RevolvingCreditArrangement	200000	usd
CY2023	fbyd	Revolving Credit Arrangement RevolvingCreditArrangement	100000	eur
CY2024Q1	srt	Bank Loans BankLoans	7221000	usd
CY2024Q1	fbyd	Percentage Of Term Loan PercentageOfTermLoan	0.10	pure
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.08875	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0003	pure
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits	2000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Capacity Available For Trade Purchases LineOfCreditFacilityCapacityAvailableForTradePurchases	3914000	usd
CY2021Q4	us-gaap	Investment Owned Foreign Currency Contract Reporting Currency Amount Current Value InvestmentOwnedForeignCurrencyContractReportingCurrencyAmountCurrentValue	10000000	usd
CY2020Q2	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	1500000	eur
CY2021Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	12785000	usd
CY2021Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.0275	pure
CY2019Q1	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	7000000	eur
CY2021Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.02	pure
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2100000	usd
CY2023Q1	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	100000	usd
CY2024Q1	fbyd	Outstanding Balance Conversion Of Debt OutstandingBalanceConversionOfDebt	1800000	usd
CY2023Q4	srt	Bank Loans BankLoans	600000	usd
CY2024Q1	fbyd	Revolving Credit Arrangement RevolvingCreditArrangement	200000	usd
CY2023	fbyd	Revolving Credit Arrangement RevolvingCreditArrangement	100000	eur
CY2022Q4	fbyd	Conversion Agreement ConversionAgreement	12800000	usd
CY2022Q4	fbyd	Stock Issued During Predecessor Financing Units StockIssuedDuringPredecessorFinancingUnits	80	shares
CY2024Q1	srt	Bank Loans BankLoans	7221000	usd
CY2024Q1	fbyd	Percentage Of Term Loan PercentageOfTermLoan	0.10	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0003	pure
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits	2000000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	pure
CY2024Q1	fbyd	Warrant Liabilities WarrantLiabilities	3691000	usd
CY2024Q1	fbyd	Earnout Liabilities EarnoutLiabilities	370026000	usd
CY2024Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	373717000	usd
CY2023Q4	fbyd	Warrant Liabilities WarrantLiabilities	3904000	usd
CY2023Q4	fbyd	Earnout Liabilities EarnoutLiabilities	488641000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	492545000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Share Price SharePrice	10.25
CY2024Q1	fbyd	Earnout Period Beginnings EarnoutPeriodBeginnings	2023-07-01
CY2024Q1	fbyd	Earnout Period Ending EarnoutPeriodEnding	2024-12-31
CY2024Q1	fbyd	Equity Volatility Ebitda Volatility EquityVolatilityEBITDAVolatility	0.25	pure
CY2024Q1	fbyd	Revenue Volatility RevenueVolatility	0.10	pure
CY2024Q1	fbyd	Revenuestock Price Correlation RevenuestockPriceCorrelation	0.45	pure
CY2024Q1	fbyd	Ebitd Astock Price Correlation EBITDAstockPriceCorrelation	0.35	pure
CY2024Q1	fbyd	Revenue Discount Rate RevenueDiscountRate	0.0937	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5198420	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	931437	shares
CY2023Q1	fbyd	Transaction Expenses TransactionExpenses		usd
CY2024Q1	fbyd	Warrant Liabilities WarrantLiabilities	3691000	usd
CY2024Q1	fbyd	Earnout Liabilities EarnoutLiabilities	370026000	usd
CY2024Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	373717000	usd
CY2023Q4	fbyd	Warrant Liabilities WarrantLiabilities	3904000	usd
CY2023Q4	fbyd	Earnout Liabilities EarnoutLiabilities	488641000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	492545000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Share Price SharePrice	10.25
CY2024Q1	fbyd	Earnout Period Beginnings EarnoutPeriodBeginnings	2023-07-01
CY2024Q1	fbyd	Earnout Period Ending EarnoutPeriodEnding	2024-12-31
CY2024Q1	fbyd	Equity Volatility Ebitda Volatility EquityVolatilityEBITDAVolatility	0.25	pure
CY2024Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.65	pure
CY2024Q1	fbyd	Revenue Volatility RevenueVolatility	0.10	pure
CY2024Q1	fbyd	Revenuestock Price Correlation RevenuestockPriceCorrelation	0.45	pure
CY2024Q1	fbyd	Ebitd Astock Price Correlation EBITDAstockPriceCorrelation	0.35	pure
CY2024Q1	fbyd	Revenue Discount Rate RevenueDiscountRate	0.0937	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	488641000	usd
CY2024Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-118615000	usd
CY2024Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	370026000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	30000000
CY2024Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.0001
CY2024Q1	us-gaap	Shares Issued SharesIssued	12000000	shares
CY2024Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	114024000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	96855000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17169000	usd
CY2024Q1	fbyd	Adjustment For Dilutive Earn Out Unit At Falcons Beyond Global Llc AdjustmentForDilutiveEarnOutUnitAtFalconsBeyondGlobalLLC	-3083000	usd
CY2024Q1	fbyd	Dilutive Net Income Attributable To Class A Common Stockin Dollars Per Share DilutiveNetIncomeAttributableToClassACommonStockinDollarsPerShare	14086000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9021520	shares
CY2024Q1	fbyd	Adjustment For Dilutive Class A Earnout Shares AdjustmentForDilutiveClassAEarnoutShares	187500	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9209020	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.9
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.53
CY2024Q1	fbyd	Class A Earnout Shares ClassAEarnoutShares	1750000	shares
CY2024Q1	fbyd	Class B Earnout Shares ClassBEarnoutShares	68250000	shares
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	488641000	usd
CY2024Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-118615000	usd
CY2024Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	370026000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	30000000
CY2024Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.0001
CY2024Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	114024000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	96855000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17169000	usd
CY2024Q1	fbyd	Adjustment For Dilutive Earn Out Unit At Falcons Beyond Global Llc AdjustmentForDilutiveEarnOutUnitAtFalconsBeyondGlobalLLC	-3083000	usd
CY2024Q1	fbyd	Dilutive Net Income Attributable To Class A Common Stockin Dollars Per Share DilutiveNetIncomeAttributableToClassACommonStockinDollarsPerShare	14086000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9021520	shares
CY2024Q1	fbyd	Adjustment For Dilutive Class A Earnout Shares AdjustmentForDilutiveClassAEarnoutShares	187500	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9209020	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.9
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.53
CY2024Q1	fbyd	Class A Earnout Shares ClassAEarnoutShares	1750000	shares
CY2024Q1	fbyd	Class B Earnout Shares ClassBEarnoutShares	68250000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5198420	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	931437	shares
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense		usd
CY2023Q1	fbyd	Transaction Expenses TransactionExpenses		usd
CY2024Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	7349	shares
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	488600000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	usd
CY2024Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	200000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	7349	shares
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	488600000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	usd
CY2024Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	200000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability		usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic		usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic		shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding		shares
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax		usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability		usd
CY2023Q1	fbyd	Fair Value Adjustment Of Of Earnouts FairValueAdjustmentOfOfEarnouts		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2024Q1	fbyd	Increase Decrease In Other Current Assets Relatedparty IncreaseDecreaseInOtherCurrentAssetsRelatedparty		usd
CY2024Q1	fbyd	Increase Decrease In Capitalization Of Ride Media Content IncreaseDecreaseInCapitalizationOfRideMediaContent		usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
CY2024Q1	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent		usd
CY2024Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities		usd
CY2023Q1	fbyd	Shortterm Advances To Affiliates ShorttermAdvancesToAffiliates		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2024Q1	fbyd	Operating Lease Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities OperatingLeaseRightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities		usd
CY2023Q1	fbyd	Conversion Of Warrants To Common Shares Class A ConversionOfWarrantsToCommonSharesClassA		usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense		usd
CY2024Q1	us-gaap	Production Tax Expense ProductionTaxExpense		usd
CY2024Q1	fbyd	Attraction Hardware And Turnkey Sales AttractionHardwareAndTurnkeySales		usd
CY2023Q1	fbyd	Disaggregated Componentsof Other Revenue DisaggregatedComponentsofOtherRevenue		usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2024Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals		usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001937987
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability		usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic		usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic		shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding		shares
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q1	fbyd	Gain Loss On Fair Value Of Earn Out Liability GainLossOnFairValueOfEarnOutLiability		usd
CY2023Q1	fbyd	Fair Value Adjustment Of Of Earnouts FairValueAdjustmentOfOfEarnouts		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2024Q1	fbyd	Increase Decrease In Other Current Assets Relatedparty IncreaseDecreaseInOtherCurrentAssetsRelatedparty		usd
CY2024Q1	fbyd	Increase Decrease In Capitalization Of Ride Media Content IncreaseDecreaseInCapitalizationOfRideMediaContent		usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
CY2024Q1	us-gaap	Increase Decrease In Due From Other Related Parties Current IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent		usd
CY2024Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities		usd
CY2023Q1	fbyd	Shortterm Advances To Affiliates ShorttermAdvancesToAffiliates		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2024Q1	fbyd	Operating Lease Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities OperatingLeaseRightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities		usd
CY2023Q1	fbyd	Conversion Of Warrants To Common Shares Class A ConversionOfWarrantsToCommonSharesClassA		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense		usd
CY2024Q1	us-gaap	Production Tax Expense ProductionTaxExpense		usd
CY2024Q1	fbyd	Attraction Hardware And Turnkey Sales AttractionHardwareAndTurnkeySales		usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals		usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001937987

Files In Submission

Name	View Source	Status
0001213900-24-044383-index-headers.html	Edgar Link	pending
0001213900-24-044383-index.html	Edgar Link	pending
0001213900-24-044383.txt	Edgar Link	pending
0001213900-24-044383-xbrl.zip	Edgar Link	pending
ea0206179-10q_falcons.htm	Edgar Link	pending
ea020617901ex31-1_falcons.htm	Edgar Link	pending
ea020617901ex31-2_falcons.htm	Edgar Link	pending
ea020617901ex32_falcons.htm	Edgar Link	pending
fbyd-20240331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0206179-10q_falcons_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fbyd-20240331_cal.xml	Edgar Link	unprocessable
fbyd-20240331_def.xml	Edgar Link	unprocessable
fbyd-20240331_lab.xml	Edgar Link	unprocessable
fbyd-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FBYD
Falcon's Beyond Global, Inc. Stock $fbyd

2024 Q1 Form 10-Q Financial Statement

#000121390024044383 Filed on May 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FBYD Falcon's Beyond Global, Inc. Stock $fbyd

2024 Q1 Form 10-Q Financial Statement

#000121390024044383 Filed on May 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FBYD
Falcon's Beyond Global, Inc. Stock $fbyd